HU9700071D0 - Use of muramilpeptides - Google Patents

Use of muramilpeptides

Info

Publication number
HU9700071D0
HU9700071D0 HU9700071A HU9700071A HU9700071D0 HU 9700071 D0 HU9700071 D0 HU 9700071D0 HU 9700071 A HU9700071 A HU 9700071A HU 9700071 A HU9700071 A HU 9700071A HU 9700071 D0 HU9700071 D0 HU 9700071D0
Authority
HU
Hungary
Prior art keywords
muramilpeptides
Prior art date
Application number
HU9700071A
Other languages
Hungarian (hu)
Other versions
HUT77290A (en
Inventor
Philip Ledger
Original Assignee
Peptech Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptech Uk Ltd filed Critical Peptech Uk Ltd
Publication of HU9700071D0 publication Critical patent/HU9700071D0/en
Publication of HUT77290A publication Critical patent/HUT77290A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
HU9700071A 1994-07-11 1995-07-10 Use of muramyl peptide compounds HUT77290A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9413935A GB9413935D0 (en) 1994-07-11 1994-07-11 Use of maramyl peptide compounds
CN95194573A CN1155245A (en) 1994-07-11 1995-07-10 Use of muramyl peptide compounds

Publications (2)

Publication Number Publication Date
HU9700071D0 true HU9700071D0 (en) 1997-02-28
HUT77290A HUT77290A (en) 1998-03-30

Family

ID=25743816

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9700071A HUT77290A (en) 1994-07-11 1995-07-10 Use of muramyl peptide compounds

Country Status (13)

Country Link
EP (1) EP0768888A1 (en)
JP (1) JPH10505580A (en)
CN (1) CN1155245A (en)
AU (1) AU2893595A (en)
BG (1) BG101126A (en)
CA (1) CA2194678A1 (en)
CZ (1) CZ4797A3 (en)
GB (1) GB9413935D0 (en)
HU (1) HUT77290A (en)
IL (1) IL114542A0 (en)
SK (1) SK2697A3 (en)
WO (1) WO1996001645A1 (en)
ZA (1) ZA955763B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998046251A1 (en) * 1997-04-11 1998-10-22 Oleg Vitalievich Kaljuzhin Immunomodulator and pharmaceutical compositions with antitumor properties, and a food additive
GB9710351D0 (en) * 1997-05-20 1997-07-16 Scotia Holdings Plc Glucosamine fatty acids
WO1999062537A1 (en) * 1998-06-04 1999-12-09 The Rockefeller University Methods and agents for modulating the immune response and inflammation involving monocyte and dendritic cell membrane proteins
DE10106852A1 (en) * 2001-02-14 2002-09-05 T Luger Anti-inflammatory compounds
FR2899466B1 (en) * 2006-04-07 2008-09-26 Oreal USE OF C-GLYCOSIDE COMPOUND ACTIVATING AGENT AND REGULATOR OF SKIN IMMUNITY
WO2008048076A1 (en) 2006-10-20 2008-04-24 Amorepacific Corporation A composition for treatment of atopic dermatitis comprising glucosamine and derivatives thereof and a method for treatment of atopic dermatitis using them
WO2008070564A1 (en) * 2006-12-01 2008-06-12 The Government Of The U.S.A, As Represented By The Secretary, Departmentof Health And Human Services Uses of muramyl dipeptide (mdp) for treating inflammation
FR2933984B1 (en) * 2008-07-15 2013-01-04 Univ Bourgogne D, D MURAMYLDIPEPTIDE, DERIVATIVE COMPOUNDS AND USE FOR THE TREATMENT OF ATHEROMOUS PLAQUES
US10610564B2 (en) 2015-02-26 2020-04-07 Stc.Unm IRGM and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
EP3387005B1 (en) 2015-12-10 2022-08-24 Bharat Biotech International Limited Novel muramyl peptide derivative compound, synthesis and uses thereof
EP3389643B1 (en) * 2015-12-15 2023-05-03 Bharat Biotech International Limited Novel muramyl peptide derivative compound, synthesis and uses thereof
CA3212571A1 (en) 2021-03-19 2022-09-22 Trained Therapeutix Discovery, Inc. Compounds for regulating trained immunity, and their methods of use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4357322A (en) * 1980-07-29 1982-11-02 Syntex (U.S.A.) Inc. Method of preventing, reducing or inhibiting inflammation
US4698330A (en) * 1983-06-27 1987-10-06 President & Fellows Of Harvard College Somnogenic compositions and method of use
HU205147B (en) * 1989-06-29 1992-03-30 Sandoz Ag Process for producing muramyl dipeptide derivative and pharmaceutical compostions comprising same
US5506204A (en) * 1991-11-19 1996-04-09 Peptech (Uk) Limited Muramyl compounds for treatment of septic shock
GB9204354D0 (en) * 1992-02-28 1992-04-08 Biokine Tech Ltd Compounds for medicinal use
GB9320820D0 (en) * 1993-10-08 1993-12-01 Biokine Tech Ltd Compounds for medicinal use
GB9326518D0 (en) * 1993-12-29 1994-03-02 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
GB9413935D0 (en) 1994-08-31
JPH10505580A (en) 1998-06-02
AU2893595A (en) 1996-02-09
SK2697A3 (en) 1997-08-06
CZ4797A3 (en) 1997-07-16
WO1996001645A1 (en) 1996-01-25
HUT77290A (en) 1998-03-30
BG101126A (en) 1997-09-30
IL114542A0 (en) 1995-11-27
CA2194678A1 (en) 1996-01-25
ZA955763B (en) 1997-01-13
CN1155245A (en) 1997-07-23
EP0768888A1 (en) 1997-04-23

Similar Documents

Publication Publication Date Title
GB2298422B (en) Compounds and their use
PL311736A1 (en) Derivatives of 1h-imidazoles
GB9526560D0 (en) Use of 2-Amino-Heterocycles
IL113248A0 (en) Use of alpha - 1c specific compounds
GB9418762D0 (en) Use of substituted cyclopentane-DI-and-triones
ZA957113B (en) Use of N-substituted pyhenothiazines
HU9700071D0 (en) Use of muramilpeptides
PL312692A1 (en) New derivatives of dialkoxy-pyridinol-benzimidazole
ZA959517B (en) Leutherobin and analogs thereof
SG42329A1 (en) Use of phenylcyclohexylcarboxamides
GB9411045D0 (en) Compounds and use
IL113992A0 (en) Use of copolymer-1
ZA932553B (en) New use of B-carbolines
IL108595A0 (en) Novel derivatives of tetramethylcyclopropane
GB9508637D0 (en) New use
NZ295530A (en) Preparation of 1-halo-3-trialkylsilanyl-benzenes
EP0797592A4 (en) Human stanniocalcin-alpha
ZA9510848B (en) Mutable composition
KR0107727Y1 (en) Crutch
ZA947865B (en) Human glactokinase
GB9403333D0 (en) Compound and use
PL313849A1 (en) Beta-aminoesters of o-hydrobenzylamides
EP0795006A4 (en) HUMAN MutT2
GB9422764D0 (en) Use of compound
ZA963484B (en) New use

Legal Events

Date Code Title Description
DFC4 Cancellation of temporary protection due to refusal